GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (WBO:VLA) » Definitions » Ending Cash Position

Valneva SE (WBO:VLA) Ending Cash Position : €168.3 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Valneva SE Ending Cash Position?

Valneva SE's Ending Cash Position for the quarter that ended in Dec. 2024 was €168.3 Mil.

Valneva SE's quarterly Ending Cash Position increased from Jun. 2024 (€131.4 Mil) to Sep. 2024 (€156.3 Mil) and increased from Sep. 2024 (€156.3 Mil) to Dec. 2024 (€168.3 Mil).

Valneva SE's annual Ending Cash Position declined from Dec. 2022 (€286.5 Mil) to Dec. 2023 (€126.1 Mil) but then increased from Dec. 2023 (€126.1 Mil) to Dec. 2024 (€168.3 Mil).


Valneva SE Ending Cash Position Historical Data

The historical data trend for Valneva SE's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Ending Cash Position Chart

Valneva SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 204.44 346.64 286.53 126.08 168.27

Valneva SE Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 126.08 176.64 131.41 156.34 168.27

Valneva SE Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Valneva SE's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=126.08+42.191
=168.3

Valneva SE's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=156.334+11.937
=168.3


Valneva SE Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Valneva SE's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Valneva SE Business Description

Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Valneva SE Headlines

No Headlines